- The key vendors in the Global Proton Therapy Market 2014-2018 are Hitachi Ltd., IBA Proton Therapy, Mitsubishi Electric Corp. and Varian Medical Systems Inc.
London, 30 September 2014: TechNavio, an independent tech-focused global research firm, announced today the publication of its market research report on the Global Proton Therapy Market 2014-2018. One key trend emerging in the market is the rise in demand for proton therapy leading to the implementation of more proton therapy centers, consequently resulting in market growth.
Proton therapy is a type of particle therapy that uses proton beams to treat cancer. The main advantage of proton therapy is that, while destroying the target malignant cells, it causes minimal damage to the surrounding cells. It uses the ionization technique to inhibit cell proliferation. Protons move slowly through the body and interact with electrons and discharge energy.
“Currently, the awareness of proton therapy is limited among cancer patients worldwide. The maximum number of centers for proton therapy is located in the US, followed by Japan,” says Faisal Ghaus, Vice President of TechNavio Research.
“Organizations such as the National Association for Proton Therapy, Pediatric Proton Foundation, and Brotherhood of the Balloon are working to increase the awareness level of proton therapy among cancer patients worldwide.
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3E%C2%A0%3C/p%3E%3Cp%3EIf%20you%20are%20in…
